As noted above, an analysis of >2200 breast cancer patients showed that several different breast cancer subtypes determined by gene expression overexpress CCR5, including triple-negative breast cancer (TNBC), >90% of Her2+ BCa, and 30–40% of luminal breast cancer [9]. This evidence concerns the gene CCR5 and triple-negative breast carcinoma.